We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » As FDA Dawdles on Interchangeability, Expert Questions Whether It’s Doable
As FDA Dawdles on Interchangeability, Expert Questions Whether It’s Doable
August 17, 2012
Companies blazing a path in the biosimilars arena likely have a long wait before their products can achieve an interchangeability designation, as the FDA admits to slow progress on that standard.